UniProt ID | TCPQ_HUMAN | |
---|---|---|
UniProt AC | P50990 | |
Protein Name | T-complex protein 1 subunit theta | |
Gene Name | CCT8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 548 | |
Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Cytoplasm, cytoskeleton, cilium basal body . | |
Protein Description | Molecular chaperone; assists the folding of proteins upon ATP hydrolysis. As part of the BBS/CCT complex may play a role in the assembly of BBSome, a complex involved in ciliogenesis regulating transports vesicles to the cilia. Known to play a role, in vitro, in the folding of actin and tubulin.. | |
Protein Sequence | MALHVPKAPGFAQMLKEGAKHFSGLEEAVYRNIQACKELAQTTRTAYGPNGMNKMVINHLEKLFVTNDAATILRELEVQHPAAKMIVMASHMQEQEVGDGTNFVLVFAGALLELAEELLRIGLSVSEVIEGYEIACRKAHEILPNLVCCSAKNLRDIDEVSSLLRTSIMSKQYGNEVFLAKLIAQACVSIFPDSGHFNVDNIRVCKILGSGISSSSVLHGMVFKKETEGDVTSVKDAKIAVYSCPFDGMITETKGTVLIKTAEELMNFSKGEENLMDAQVKAIADTGANVVVTGGKVADMALHYANKYNIMLVRLNSKWDLRRLCKTVGATALPRLTPPVLEEMGHCDSVYLSEVGDTQVVVFKHEKEDGAISTIVLRGSTDNLMDDIERAVDDGVNTFKVLTRDKRLVPGGGATEIELAKQITSYGETCPGLEQYAIKKFAEAFEAIPRALAENSGVKANEVISKLYAVHQEGNKNVGLDIEAEVPAVKDMLEAGILDTYLGKYWAIKLATNAAVTVLRVDQIIMAKPAGGPKPPSGKKDWDDDQND | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MALHVPKAP ------CCCCCCCCC | 13.33 | - | |
7 | Ubiquitination | -MALHVPKAPGFAQM -CCCCCCCCCCHHHH | 67.15 | 21890473 | |
7 | Acetylation | -MALHVPKAPGFAQM -CCCCCCCCCCHHHH | 67.15 | 19608861 | |
7 | Malonylation | -MALHVPKAPGFAQM -CCCCCCCCCCHHHH | 67.15 | 26320211 | |
7 | Ubiquitination | -MALHVPKAPGFAQM -CCCCCCCCCCHHHH | 67.15 | 21890473 | |
14 | Sulfoxidation | KAPGFAQMLKEGAKH CCCCHHHHHHHHHHH | 5.32 | 28465586 | |
16 | Ubiquitination | PGFAQMLKEGAKHFS CCHHHHHHHHHHHCC | 49.08 | 21890473 | |
16 | Acetylation | PGFAQMLKEGAKHFS CCHHHHHHHHHHHCC | 49.08 | 25953088 | |
16 | Malonylation | PGFAQMLKEGAKHFS CCHHHHHHHHHHHCC | 49.08 | 26320211 | |
16 | Ubiquitination | PGFAQMLKEGAKHFS CCHHHHHHHHHHHCC | 49.08 | 21890473 | |
18 | Ubiquitination | FAQMLKEGAKHFSGL HHHHHHHHHHHCCCH | 38.03 | - | |
20 | Ubiquitination | QMLKEGAKHFSGLEE HHHHHHHHHCCCHHH | 56.91 | 21890473 | |
20 | Acetylation | QMLKEGAKHFSGLEE HHHHHHHHHCCCHHH | 56.91 | 16916647 | |
20 | Malonylation | QMLKEGAKHFSGLEE HHHHHHHHHCCCHHH | 56.91 | 26320211 | |
20 | Ubiquitination | QMLKEGAKHFSGLEE HHHHHHHHHCCCHHH | 56.91 | 21890473 | |
23 | Phosphorylation | KEGAKHFSGLEEAVY HHHHHHCCCHHHHHH | 42.03 | 30266825 | |
30 | Phosphorylation | SGLEEAVYRNIQACK CCHHHHHHHHHHHHH | 12.65 | 25159151 | |
35 | Ubiquitination | AVYRNIQACKELAQT HHHHHHHHHHHHHHH | 11.53 | - | |
36 | Glutathionylation | VYRNIQACKELAQTT HHHHHHHHHHHHHHH | 1.70 | 22555962 | |
36 | S-palmitoylation | VYRNIQACKELAQTT HHHHHHHHHHHHHHH | 1.70 | 26865113 | |
37 | 2-Hydroxyisobutyrylation | YRNIQACKELAQTTR HHHHHHHHHHHHHHC | 59.80 | - | |
37 | Acetylation | YRNIQACKELAQTTR HHHHHHHHHHHHHHC | 59.80 | 26051181 | |
37 | Ubiquitination | YRNIQACKELAQTTR HHHHHHHHHHHHHHC | 59.80 | 21906983 | |
43 | Ubiquitination | CKELAQTTRTAYGPN HHHHHHHHCCCCCCC | 17.59 | - | |
54 | Ubiquitination | YGPNGMNKMVINHLE CCCCHHHHHHHHHHH | 26.17 | 21890473 | |
54 | Ubiquitination | YGPNGMNKMVINHLE CCCCHHHHHHHHHHH | 26.17 | 21890473 | |
55 | Sulfoxidation | GPNGMNKMVINHLEK CCCHHHHHHHHHHHH | 2.88 | 30846556 | |
62 | Ubiquitination | MVINHLEKLFVTNDA HHHHHHHHHHCCCCH | 54.29 | 21890473 | |
62 | 2-Hydroxyisobutyrylation | MVINHLEKLFVTNDA HHHHHHHHHHCCCCH | 54.29 | - | |
62 | Acetylation | MVINHLEKLFVTNDA HHHHHHHHHHCCCCH | 54.29 | 25953088 | |
62 | Ubiquitination | MVINHLEKLFVTNDA HHHHHHHHHHCCCCH | 54.29 | 21890473 | |
66 | Phosphorylation | HLEKLFVTNDAATIL HHHHHHCCCCHHHHH | 21.75 | 22210691 | |
71 | Phosphorylation | FVTNDAATILRELEV HCCCCHHHHHHHHHC | 23.43 | 27050516 | |
119 | Ubiquitination | LELAEELLRIGLSVS HHHHHHHHHHCCCHH | 4.19 | - | |
133 | Ubiquitination | SEVIEGYEIACRKAH HHHHCCHHHHCHHHH | 34.66 | - | |
138 | Acetylation | GYEIACRKAHEILPN CHHHHCHHHHHHHCC | 54.71 | 26051181 | |
138 | Ubiquitination | GYEIACRKAHEILPN CHHHHCHHHHHHHCC | 54.71 | - | |
148 | S-nitrosocysteine | EILPNLVCCSAKNLR HHHCCCEEEECCCCC | 1.38 | - | |
148 | S-nitrosylation | EILPNLVCCSAKNLR HHHCCCEEEECCCCC | 1.38 | 22178444 | |
149 | S-nitrosocysteine | ILPNLVCCSAKNLRD HHCCCEEEECCCCCC | 3.27 | - | |
149 | Glutathionylation | ILPNLVCCSAKNLRD HHCCCEEEECCCCCC | 3.27 | 22555962 | |
149 | S-nitrosylation | ILPNLVCCSAKNLRD HHCCCEEEECCCCCC | 3.27 | 22178444 | |
150 | Phosphorylation | LPNLVCCSAKNLRDI HCCCEEEECCCCCCH | 36.83 | 28450419 | |
152 | Ubiquitination | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | 21890473 | |
152 | Ubiquitination | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | 21890473 | |
152 | 2-Hydroxyisobutyrylation | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | - | |
152 | Acetylation | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | 25953088 | |
152 | Malonylation | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | 26320211 | |
152 | Ubiquitination | NLVCCSAKNLRDIDE CCEEEECCCCCCHHH | 39.97 | 21890473 | |
161 | Phosphorylation | LRDIDEVSSLLRTSI CCCHHHHHHHHHHHH | 17.14 | 20873877 | |
162 | Phosphorylation | RDIDEVSSLLRTSIM CCHHHHHHHHHHHHH | 36.28 | 25262027 | |
171 | Ubiquitination | LRTSIMSKQYGNEVF HHHHHHHHHHCCHHH | 30.11 | 21890473 | |
171 | 2-Hydroxyisobutyrylation | LRTSIMSKQYGNEVF HHHHHHHHHHCCHHH | 30.11 | - | |
171 | Acetylation | LRTSIMSKQYGNEVF HHHHHHHHHHCCHHH | 30.11 | 27452117 | |
171 | Ubiquitination | LRTSIMSKQYGNEVF HHHHHHHHHHCCHHH | 30.11 | 21906983 | |
173 | Phosphorylation | TSIMSKQYGNEVFLA HHHHHHHHCCHHHHH | 26.17 | 28152594 | |
206 | Acetylation | VDNIRVCKILGSGIS CCCEEEEEECCCCCC | 37.80 | - | |
206 | Ubiquitination | VDNIRVCKILGSGIS CCCEEEEEECCCCCC | 37.80 | - | |
206 | Acetylation | VDNIRVCKILGSGIS CCCEEEEEECCCCCC | 37.80 | 26051181 | |
210 | Phosphorylation | RVCKILGSGISSSSV EEEEECCCCCCCHHH | 29.52 | 21406692 | |
213 | Phosphorylation | KILGSGISSSSVLHG EECCCCCCCHHHEEC | 27.91 | 21406692 | |
214 | Phosphorylation | ILGSGISSSSVLHGM ECCCCCCCHHHEECE | 25.39 | 21406692 | |
215 | Phosphorylation | LGSGISSSSVLHGMV CCCCCCCHHHEECEE | 20.06 | 21406692 | |
216 | Ubiquitination | GSGISSSSVLHGMVF CCCCCCHHHEECEEE | 30.55 | - | |
216 | Phosphorylation | GSGISSSSVLHGMVF CCCCCCHHHEECEEE | 30.55 | 21406692 | |
224 | 2-Hydroxyisobutyrylation | VLHGMVFKKETEGDV HEECEEEECCCCCCC | 37.99 | - | |
224 | Acetylation | VLHGMVFKKETEGDV HEECEEEECCCCCCC | 37.99 | 25038526 | |
224 | Sumoylation | VLHGMVFKKETEGDV HEECEEEECCCCCCC | 37.99 | 28112733 | |
224 | Ubiquitination | VLHGMVFKKETEGDV HEECEEEECCCCCCC | 37.99 | - | |
225 | Acetylation | LHGMVFKKETEGDVT EECEEEECCCCCCCC | 59.40 | 23236377 | |
225 | Ubiquitination | LHGMVFKKETEGDVT EECEEEECCCCCCCC | 59.40 | 17370265 | |
227 | Phosphorylation | GMVFKKETEGDVTSV CEEEECCCCCCCCCC | 54.90 | 20068231 | |
232 | Phosphorylation | KETEGDVTSVKDAKI CCCCCCCCCCCCCEE | 32.32 | 29255136 | |
233 | Phosphorylation | ETEGDVTSVKDAKIA CCCCCCCCCCCCEEE | 27.33 | 29255136 | |
235 | Ubiquitination | EGDVTSVKDAKIAVY CCCCCCCCCCEEEEE | 52.30 | - | |
235 | Acetylation | EGDVTSVKDAKIAVY CCCCCCCCCCEEEEE | 52.30 | 25953088 | |
235 | Ubiquitination | EGDVTSVKDAKIAVY CCCCCCCCCCEEEEE | 52.30 | 17370265 | |
238 | 2-Hydroxyisobutyrylation | VTSVKDAKIAVYSCP CCCCCCCEEEEEECC | 41.13 | - | |
238 | Acetylation | VTSVKDAKIAVYSCP CCCCCCCEEEEEECC | 41.13 | 25038526 | |
241 | Ubiquitination | VKDAKIAVYSCPFDG CCCCEEEEEECCCCC | 4.04 | - | |
242 | Phosphorylation | KDAKIAVYSCPFDGM CCCEEEEEECCCCCC | 8.78 | 28152594 | |
243 | Phosphorylation | DAKIAVYSCPFDGMI CCEEEEEECCCCCCE | 14.55 | 28152594 | |
244 | Glutathionylation | AKIAVYSCPFDGMIT CEEEEEECCCCCCEE | 1.82 | 22555962 | |
245 | Acetylation | KIAVYSCPFDGMITE EEEEEECCCCCCEEC | 25.15 | 19608861 | |
245 | Ubiquitination | KIAVYSCPFDGMITE EEEEEECCCCCCEEC | 25.15 | 19608861 | |
249 | Sulfoxidation | YSCPFDGMITETKGT EECCCCCCEECCCCE | 3.54 | 21406390 | |
251 | Acetylation | CPFDGMITETKGTVL CCCCCCEECCCCEEE | 28.80 | - | |
251 | Ubiquitination | CPFDGMITETKGTVL CCCCCCEECCCCEEE | 28.80 | - | |
251 | Phosphorylation | CPFDGMITETKGTVL CCCCCCEECCCCEEE | 28.80 | 28450419 | |
253 | Phosphorylation | FDGMITETKGTVLIK CCCCEECCCCEEEEE | 26.56 | 28857561 | |
254 | 2-Hydroxyisobutyrylation | DGMITETKGTVLIKT CCCEECCCCEEEEEC | 46.48 | - | |
254 | Sumoylation | DGMITETKGTVLIKT CCCEECCCCEEEEEC | 46.48 | 28112733 | |
254 | Ubiquitination | DGMITETKGTVLIKT CCCEECCCCEEEEEC | 46.48 | - | |
256 | Phosphorylation | MITETKGTVLIKTAE CEECCCCEEEEECHH | 17.44 | 28857561 | |
260 | Ubiquitination | TKGTVLIKTAEELMN CCCEEEEECHHHHHC | 37.21 | 21890473 | |
260 | Sumoylation | TKGTVLIKTAEELMN CCCEEEEECHHHHHC | 37.21 | 28112733 | |
260 | Ubiquitination | TKGTVLIKTAEELMN CCCEEEEECHHHHHC | 37.21 | 21906983 | |
261 | Phosphorylation | KGTVLIKTAEELMNF CCEEEEECHHHHHCC | 32.10 | - | |
266 | Sulfoxidation | IKTAEELMNFSKGEE EECHHHHHCCCCCCC | 5.57 | 21406390 | |
269 | Phosphorylation | AEELMNFSKGEENLM HHHHHCCCCCCCCHH | 34.44 | 21815630 | |
270 | Acetylation | EELMNFSKGEENLMD HHHHCCCCCCCCHHH | 67.23 | 23236377 | |
270 | Ubiquitination | EELMNFSKGEENLMD HHHHCCCCCCCCHHH | 67.23 | 21906983 | |
276 | Sulfoxidation | SKGEENLMDAQVKAI CCCCCCHHHHHHHHH | 6.39 | 21406390 | |
277 | Ubiquitination | KGEENLMDAQVKAIA CCCCCHHHHHHHHHH | 36.69 | - | |
281 | 2-Hydroxyisobutyrylation | NLMDAQVKAIADTGA CHHHHHHHHHHHCCC | 23.22 | - | |
286 | Phosphorylation | QVKAIADTGANVVVT HHHHHHHCCCCEEEE | 29.22 | 23911959 | |
288 | Ubiquitination | KAIADTGANVVVTGG HHHHHCCCCEEEECC | 14.03 | - | |
293 | Phosphorylation | TGANVVVTGGKVADM CCCCEEEECCHHHHH | 28.71 | 23911959 | |
296 | 2-Hydroxyisobutyrylation | NVVVTGGKVADMALH CEEEECCHHHHHHHH | 35.28 | - | |
296 | Acetylation | NVVVTGGKVADMALH CEEEECCHHHHHHHH | 35.28 | 26051181 | |
296 | Malonylation | NVVVTGGKVADMALH CEEEECCHHHHHHHH | 35.28 | 26320211 | |
296 | Ubiquitination | NVVVTGGKVADMALH CEEEECCHHHHHHHH | 35.28 | - | |
299 | Acetylation | VTGGKVADMALHYAN EECCHHHHHHHHHHH | 26.35 | - | |
299 | Ubiquitination | VTGGKVADMALHYAN EECCHHHHHHHHHHH | 26.35 | - | |
299 | Acetylation | VTGGKVADMALHYAN EECCHHHHHHHHHHH | 26.35 | 19608861 | |
299 | Ubiquitination | VTGGKVADMALHYAN EECCHHHHHHHHHHH | 26.35 | 19608861 | |
300 | Sulfoxidation | TGGKVADMALHYANK ECCHHHHHHHHHHHH | 2.85 | 30846556 | |
304 | Nitration | VADMALHYANKYNIM HHHHHHHHHHHCCEE | 16.84 | - | |
304 | Phosphorylation | VADMALHYANKYNIM HHHHHHHHHHHCCEE | 16.84 | 28152594 | |
307 | Acetylation | MALHYANKYNIMLVR HHHHHHHHCCEEEEE | 31.35 | - | |
307 | Ubiquitination | MALHYANKYNIMLVR HHHHHHHHCCEEEEE | 31.35 | - | |
307 | Acetylation | MALHYANKYNIMLVR HHHHHHHHCCEEEEE | 31.35 | 25953088 | |
307 | Ubiquitination | MALHYANKYNIMLVR HHHHHHHHCCEEEEE | 31.35 | - | |
308 | Phosphorylation | ALHYANKYNIMLVRL HHHHHHHCCEEEEEC | 15.10 | 23882029 | |
317 | Phosphorylation | IMLVRLNSKWDLRRL EEEEECCCHHHHHHH | 39.45 | 29978859 | |
318 | 2-Hydroxyisobutyrylation | MLVRLNSKWDLRRLC EEEECCCHHHHHHHH | 43.59 | - | |
318 | Acetylation | MLVRLNSKWDLRRLC EEEECCCHHHHHHHH | 43.59 | 19608861 | |
318 | Malonylation | MLVRLNSKWDLRRLC EEEECCCHHHHHHHH | 43.59 | 26320211 | |
318 | Ubiquitination | MLVRLNSKWDLRRLC EEEECCCHHHHHHHH | 43.59 | 19608861 | |
326 | Ubiquitination | WDLRRLCKTVGATAL HHHHHHHHHHCCCCC | 51.33 | 21890473 | |
326 | 2-Hydroxyisobutyrylation | WDLRRLCKTVGATAL HHHHHHHHHHCCCCC | 51.33 | - | |
326 | Acetylation | WDLRRLCKTVGATAL HHHHHHHHHHCCCCC | 51.33 | 23749302 | |
326 | Malonylation | WDLRRLCKTVGATAL HHHHHHHHHHCCCCC | 51.33 | 26320211 | |
326 | Ubiquitination | WDLRRLCKTVGATAL HHHHHHHHHHCCCCC | 51.33 | 21890473 | |
327 | Acetylation | DLRRLCKTVGATALP HHHHHHHHHCCCCCC | 24.15 | 19608861 | |
327 | Phosphorylation | DLRRLCKTVGATALP HHHHHHHHHCCCCCC | 24.15 | 20068231 | |
327 | Ubiquitination | DLRRLCKTVGATALP HHHHHHHHHCCCCCC | 24.15 | 19608861 | |
331 | Phosphorylation | LCKTVGATALPRLTP HHHHHCCCCCCCCCH | 23.85 | 20068231 | |
337 | Phosphorylation | ATALPRLTPPVLEEM CCCCCCCCHHHHHHC | 27.16 | 26126808 | |
348 | Acetylation | LEEMGHCDSVYLSEV HHHCCCCCEEEEECC | 35.15 | - | |
349 | Phosphorylation | EEMGHCDSVYLSEVG HHCCCCCEEEEECCC | 20.32 | 26126808 | |
351 | Phosphorylation | MGHCDSVYLSEVGDT CCCCCEEEEECCCCE | 14.41 | 26126808 | |
353 | Phosphorylation | HCDSVYLSEVGDTQV CCCEEEEECCCCEEE | 16.73 | 26126808 | |
367 | 2-Hydroxyisobutyrylation | VVVFKHEKEDGAIST EEEEEEECCCCCEEE | 61.91 | - | |
367 | Acetylation | VVVFKHEKEDGAIST EEEEEEECCCCCEEE | 61.91 | 23236377 | |
367 | Malonylation | VVVFKHEKEDGAIST EEEEEEECCCCCEEE | 61.91 | 26320211 | |
367 | Ubiquitination | VVVFKHEKEDGAIST EEEEEEECCCCCEEE | 61.91 | - | |
373 | Phosphorylation | EKEDGAISTIVLRGS ECCCCCEEEEEEECC | 16.14 | 20860994 | |
378 | Methylation | AISTIVLRGSTDNLM CEEEEEEECCCCCHH | 26.56 | - | |
380 | Phosphorylation | STIVLRGSTDNLMDD EEEEEECCCCCHHHH | 26.59 | 29255136 | |
381 | Acetylation | TIVLRGSTDNLMDDI EEEEECCCCCHHHHH | 31.56 | - | |
381 | Ubiquitination | TIVLRGSTDNLMDDI EEEEECCCCCHHHHH | 31.56 | - | |
381 | Acetylation | TIVLRGSTDNLMDDI EEEEECCCCCHHHHH | 31.56 | 19608861 | |
381 | Phosphorylation | TIVLRGSTDNLMDDI EEEEECCCCCHHHHH | 31.56 | 29255136 | |
381 | Ubiquitination | TIVLRGSTDNLMDDI EEEEECCCCCHHHHH | 31.56 | 19608861 | |
385 | Sulfoxidation | RGSTDNLMDDIERAV ECCCCCHHHHHHHHH | 5.65 | 21406390 | |
393 | Acetylation | DDIERAVDDGVNTFK HHHHHHHHCCCCEEE | 46.06 | 19608861 | |
393 | Ubiquitination | DDIERAVDDGVNTFK HHHHHHHHCCCCEEE | 46.06 | 19608861 | |
398 | Phosphorylation | AVDDGVNTFKVLTRD HHHCCCCEEEEEECC | 23.56 | 21406692 | |
400 | Ubiquitination | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | 21890473 | |
400 | 2-Hydroxyisobutyrylation | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | - | |
400 | Acetylation | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | 19608861 | |
400 | Malonylation | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | 26320211 | |
400 | Methylation | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | 19608861 | |
400 | Ubiquitination | DDGVNTFKVLTRDKR HCCCCEEEEEECCCC | 34.01 | 21890473 | |
402 | Ubiquitination | GVNTFKVLTRDKRLV CCCEEEEEECCCCCC | 3.15 | - | |
415 | Phosphorylation | LVPGGGATEIELAKQ CCCCCCHHHHHHHHH | 40.55 | 21406692 | |
420 | Ubiquitination | GATEIELAKQITSYG CHHHHHHHHHHHHCC | 6.74 | - | |
421 | Ubiquitination | ATEIELAKQITSYGE HHHHHHHHHHHHCCC | 55.66 | 21890473 | |
421 | Ubiquitination | ATEIELAKQITSYGE HHHHHHHHHHHHCCC | 55.66 | 21890473 | |
421 | Acetylation | ATEIELAKQITSYGE HHHHHHHHHHHHCCC | 55.66 | 26051181 | |
421 | Ubiquitination | ATEIELAKQITSYGE HHHHHHHHHHHHCCC | 55.66 | 21906983 | |
424 | Phosphorylation | IELAKQITSYGETCP HHHHHHHHHCCCCCC | 17.25 | 28152594 | |
425 | Phosphorylation | ELAKQITSYGETCPG HHHHHHHHCCCCCCC | 32.54 | 28152594 | |
426 | Phosphorylation | LAKQITSYGETCPGL HHHHHHHCCCCCCCH | 15.44 | 28152594 | |
429 | Phosphorylation | QITSYGETCPGLEQY HHHHCCCCCCCHHHH | 21.45 | 28152594 | |
430 | S-nitrosocysteine | ITSYGETCPGLEQYA HHHCCCCCCCHHHHH | 1.88 | - | |
430 | Glutathionylation | ITSYGETCPGLEQYA HHHCCCCCCCHHHHH | 1.88 | 22555962 | |
430 | S-nitrosylation | ITSYGETCPGLEQYA HHHCCCCCCCHHHHH | 1.88 | 19483679 | |
436 | Phosphorylation | TCPGLEQYAIKKFAE CCCCHHHHHHHHHHH | 10.83 | 28152594 | |
439 | 2-Hydroxyisobutyrylation | GLEQYAIKKFAEAFE CHHHHHHHHHHHHHH | 33.40 | - | |
439 | Acetylation | GLEQYAIKKFAEAFE CHHHHHHHHHHHHHH | 33.40 | 25953088 | |
439 | Ubiquitination | GLEQYAIKKFAEAFE CHHHHHHHHHHHHHH | 33.40 | - | |
440 | Ubiquitination | LEQYAIKKFAEAFEA HHHHHHHHHHHHHHH | 43.63 | 21890473 | |
440 | Ubiquitination | LEQYAIKKFAEAFEA HHHHHHHHHHHHHHH | 43.63 | 21890473 | |
440 | Acetylation | LEQYAIKKFAEAFEA HHHHHHHHHHHHHHH | 43.63 | 25953088 | |
440 | Succinylation | LEQYAIKKFAEAFEA HHHHHHHHHHHHHHH | 43.63 | 23954790 | |
440 | Ubiquitination | LEQYAIKKFAEAFEA HHHHHHHHHHHHHHH | 43.63 | 21890473 | |
447 | Acetylation | KFAEAFEAIPRALAE HHHHHHHHHHHHHHH | 15.61 | - | |
447 | Ubiquitination | KFAEAFEAIPRALAE HHHHHHHHHHHHHHH | 15.61 | 21890473 | |
447 | Acetylation | KFAEAFEAIPRALAE HHHHHHHHHHHHHHH | 15.61 | 19608861 | |
447 | Ubiquitination | KFAEAFEAIPRALAE HHHHHHHHHHHHHHH | 15.61 | 19608861 | |
459 | 2-Hydroxyisobutyrylation | LAENSGVKANEVISK HHHCCCCCHHHHHHH | 49.36 | - | |
459 | Sumoylation | LAENSGVKANEVISK HHHCCCCCHHHHHHH | 49.36 | 25114211 | |
459 | Ubiquitination | LAENSGVKANEVISK HHHCCCCCHHHHHHH | 49.36 | 21906983 | |
466 | Ubiquitination | KANEVISKLYAVHQE CHHHHHHHHHHHHHC | 34.10 | 21890473 | |
466 | 2-Hydroxyisobutyrylation | KANEVISKLYAVHQE CHHHHHHHHHHHHHC | 34.10 | - | |
466 | Acetylation | KANEVISKLYAVHQE CHHHHHHHHHHHHHC | 34.10 | 19608861 | |
466 | Malonylation | KANEVISKLYAVHQE CHHHHHHHHHHHHHC | 34.10 | 26320211 | |
466 | Ubiquitination | KANEVISKLYAVHQE CHHHHHHHHHHHHHC | 34.10 | 21890473 | |
468 | Nitration | NEVISKLYAVHQEGN HHHHHHHHHHHHCCC | 15.43 | - | |
468 | Phosphorylation | NEVISKLYAVHQEGN HHHHHHHHHHHHCCC | 15.43 | 28152594 | |
492 | Sulfoxidation | EVPAVKDMLEAGILD ECCHHHHHHHHCCHH | 2.78 | 30846556 | |
501 | Phosphorylation | EAGILDTYLGKYWAI HHCCHHHHHHHHHHH | 17.08 | 25147952 | |
505 | Phosphorylation | LDTYLGKYWAIKLAT HHHHHHHHHHHHHHH | 9.77 | 22817900 | |
509 | Acetylation | LGKYWAIKLATNAAV HHHHHHHHHHHCCCE | 25.07 | - | |
509 | Ubiquitination | LGKYWAIKLATNAAV HHHHHHHHHHHCCCE | 25.07 | 21890473 | |
512 | Phosphorylation | YWAIKLATNAAVTVL HHHHHHHHCCCEEEE | 35.51 | 20860994 | |
515 | Ubiquitination | IKLATNAAVTVLRVD HHHHHCCCEEEEEEC | 10.28 | - | |
517 | Phosphorylation | LATNAAVTVLRVDQI HHHCCCEEEEEECEE | 14.75 | 20860994 | |
520 | Ubiquitination | NAAVTVLRVDQIIMA CCCEEEEEECEEEEE | 26.15 | - | |
521 | Ubiquitination | AAVTVLRVDQIIMAK CCEEEEEECEEEEEC | 5.78 | - | |
526 | Sulfoxidation | LRVDQIIMAKPAGGP EEECEEEEECCCCCC | 4.13 | 21406390 | |
528 | Ubiquitination | VDQIIMAKPAGGPKP ECEEEEECCCCCCCC | 20.30 | 21890473 | |
528 | Acetylation | VDQIIMAKPAGGPKP ECEEEEECCCCCCCC | 20.30 | 23749302 | |
528 | Malonylation | VDQIIMAKPAGGPKP ECEEEEECCCCCCCC | 20.30 | 26320211 | |
528 | Methylation | VDQIIMAKPAGGPKP ECEEEEECCCCCCCC | 20.30 | - | |
528 | Ubiquitination | VDQIIMAKPAGGPKP ECEEEEECCCCCCCC | 20.30 | 21890473 | |
534 | Sumoylation | AKPAGGPKPPSGKKD ECCCCCCCCCCCCCC | 73.22 | - | |
534 | Acetylation | AKPAGGPKPPSGKKD ECCCCCCCCCCCCCC | 73.22 | 26210075 | |
534 | Sumoylation | AKPAGGPKPPSGKKD ECCCCCCCCCCCCCC | 73.22 | 28112733 | |
534 | Ubiquitination | AKPAGGPKPPSGKKD ECCCCCCCCCCCCCC | 73.22 | - | |
537 | Phosphorylation | AGGPKPPSGKKDWDD CCCCCCCCCCCCCCC | 72.30 | 23401153 | |
539 | 2-Hydroxyisobutyrylation | GPKPPSGKKDWDDDQ CCCCCCCCCCCCCCC | 52.47 | - | |
539 | Acetylation | GPKPPSGKKDWDDDQ CCCCCCCCCCCCCCC | 52.47 | 25953088 | |
539 | Sumoylation | GPKPPSGKKDWDDDQ CCCCCCCCCCCCCCC | 52.47 | 28112733 | |
539 | Ubiquitination | GPKPPSGKKDWDDDQ CCCCCCCCCCCCCCC | 52.47 | - | |
540 | Acetylation | PKPPSGKKDWDDDQN CCCCCCCCCCCCCCC | 68.52 | 12430811 | |
540 | Ubiquitination | PKPPSGKKDWDDDQN CCCCCCCCCCCCCCC | 68.52 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TCPQ_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TCPQ_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TCPQ_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
TCPZ_HUMAN | CCT6A | physical | 22939629 | |
TIF1B_HUMAN | TRIM28 | physical | 22939629 | |
VATB2_HUMAN | ATP6V1B2 | physical | 22939629 | |
UBA5_HUMAN | UBA5 | physical | 22939629 | |
TCPB_HUMAN | CCT2 | physical | 22863883 | |
AT1A1_HUMAN | ATP1A1 | physical | 26344197 | |
GFPT1_HUMAN | GFPT1 | physical | 26344197 | |
IMA3_HUMAN | KPNA4 | physical | 26344197 | |
MESD_HUMAN | MESDC2 | physical | 26344197 | |
PRS7_HUMAN | PSMC2 | physical | 26344197 | |
RPN1_HUMAN | RPN1 | physical | 26344197 | |
TBB5_HUMAN | TUBB | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7; LYS-318; LYS-400 ANDLYS-466, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-20, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND TYR-30, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-227; THR-232 ANDSER-233, AND MASS SPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-505, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry."; Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.; Proteomics 7:868-874(2007). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-225 AND LYS-235, AND MASSSPECTROMETRY. |